Compare ELVN & CLBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELVN | CLBK |
|---|---|---|
| Founded | 2016 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.2B |
| IPO Year | 2020 | 2017 |
| Metric | ELVN | CLBK |
|---|---|---|
| Price | $44.57 | $19.94 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | ★ $43.40 | $17.00 |
| AVG Volume (30 Days) | ★ 1.6M | 345.7K |
| Earning Date | 05-11-2026 | 04-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 3.17 | ★ 563.64 |
| EPS | N/A | ★ 0.13 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $3.97 |
| Revenue Next Year | N/A | $11.43 |
| P/E Ratio | ★ N/A | $154.23 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.79 | $13.66 |
| 52 Week High | $48.53 | $21.20 |
| Indicator | ELVN | CLBK |
|---|---|---|
| Relative Strength Index (RSI) | 60.92 | 50.11 |
| Support Level | $17.90 | $19.69 |
| Resistance Level | $48.53 | $20.69 |
| Average True Range (ATR) | 3.13 | 0.44 |
| MACD | 0.97 | -0.11 |
| Stochastic Oscillator | 83.75 | 22.59 |
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
Columbia Financial Inc is a federally chartered savings bank that serves the financial needs of depositors and the local community as a customer service-focused institution. The company offers traditional financial services to businesses and consumers in its market areas. It attracts deposits from the general public and uses those funds to originate various loans, including multifamily and commercial real estate loans, commercial business loans, one-to-four family real estate loans, construction loans, home equity loans and advances, and other consumer loans. The company also offers title insurance through its wholly owned subsidiary and provides a broad range of insurance products, including personal and business lines of insurance, mainly to customers and New Jersey residents.